Which super funds hold GlaxoSmithKline Capital Inc?
As at 31 December 2025, 10 Australian super investment options in our dataset held GlaxoSmithKline Capital Inc, the largest weighting being 0.02% in Diversified Fixed Interest (Accumulation) (AustralianSuper).
Options holding it
10
Largest weighting
0.02%
Diversified Fixed Interest (Accumulation) · AustralianSuper
Australian super investment options disclosing a holding in GlaxoSmithKline Capital Inc. Figures aggregate each option's disclosed line items for this security, as at each option's own reporting date.
| Fund | Phase | Option | Weighting | Value (AUD) | As at |
|---|---|---|---|---|---|
| AustralianSuper | Accumulation | Balanced (Accumulation) | 0.00% | $4,829,365 | 31 December 2025 |
| AustralianSuper | Retirement | Balanced (Income) | 0.00% | $640,866 | 31 December 2025 |
| AustralianSuper | Retirement | Conservative Balanced (Income) | 0.00% | $298,464 | 31 December 2025 |
| AustralianSuper | Accumulation | Stable (Accumulation) | 0.00% | $261,475 | 31 December 2025 |
| AustralianSuper | Accumulation | Conservative Balanced (Accumulation) | 0.00% | $247,265 | 31 December 2025 |
| AustralianSuper | Retirement | Stable (Income) | 0.00% | $240,540 | 31 December 2025 |
| AustralianSuper | Accumulation | Diversified Fixed Interest (Accumulation) | 0.02% | $199,850 | 31 December 2025 |
| AustralianSuper | Accumulation | High Growth (Accumulation) | 0.00% | $158,468 | 31 December 2025 |
| AustralianSuper | Retirement | Diversified Fixed Interest (Income) | 0.02% | $94,531 | 31 December 2025 |
| AustralianSuper | Retirement | High Growth (Income) | 0.00% | $10,630 | 31 December 2025 |
This page surfaces figures disclosed by the funds themselves under Portfolio Holdings Disclosure (Schedule 8D), each as at the date shown. It is factual disclosure information, not financial advice or a recommendation.
Methodology — how holdings are sourced, resolved and aggregated.